NuVasive (NUVA) says it's obtained the release of $62.5M from a restricted escrow account in relation to the reversal of a decision in it's trademark dispute regarding the NeuroVision trade name. In January 2011, an unfavorable judgment was entered against NUVA in the amount of $60M plus attorney fees and costs, for which it subsequently transferred $62.5M into a restricted escrow account to secure the judgment. The plaintiff has not appealed, thus enabling the company to secure the release of the funds.
NuVasive (NUVA) says it's obtained the release of $62.5M from a restricted escrow account in...
From other sites
at CNBC.com (Oct 4, 2012)
at CNBC.com (Oct 3, 2012)
at CNBC.com (Jun 28, 2012)
at CNBC.com (Jun 23, 2010)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs